Clinical Evidence

MyPath Melanoma and DiffDx-Melanoma are validated to more accurately diagnose lesions of unknown malignant potential as benign, intermediate, or malignant. This provides information to your physician that allows them to make a more confident diagnosis, follow-up, and treatment plan. 


Twelve published studies


Patients Tested

MyPath Melanoma or DiffDx-Melanoma May Be Right for You

Talk to your healthcare provider and healthcare team to learn more about how MyPath Melanoma or DiffDx-Melanoma test results can be used to help better diagnose your lesion to personalize your treatment and ongoing management.

What’s Next?

What Is the Testing Process?

How Do You Get a Test?